Literature DB >> 28214755

Identification of a new tert-leucinate class synthetic cannabinoid in powder and "spice-like" herbal incenses: Methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (5F-MDMB-PICA).

Martijn D P Risseeuw1, Peter Blanckaert2, Vera Coopman3, Stijn Van Quekelberghe3, Serge Van Calenbergh1, Jan Cordonnier4.   

Abstract

A brown powder and different product packages of "spice-like" herbal incenses were analyzed using a systematic identification approach based on liquid chromatography with diode array detector (HPLC-PDA) and gas chromatography mass spectrometry (GC-MS) with computer based library search against spectral libraries. However, the most predominant compound in the methanolic sample solutions could not be identified. In order to elucidate the chemical structure, a more extensive analysis of the material was initiated using liquid chromatography mass spectrometry (LC-MS), electrospray high resolution mass spectrometry (ESI-HRMS) and 1H, 13C and 19F nuclear magnetic resonance spectroscopy (NMR), which allowed the identification and characterization of the major compound as methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (5F-MDMB-PICA). The goal of this study is to provide analytical information for the identification of this new tert-leucinate class synthetic cannabinoid by various analytical methods.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5F-MDMB-PICA; ESI-HRMS; GC–MS; HPLC–PDA; LC–MS; NMR; Synthetic cannabinoid

Year:  2017        PMID: 28214755     DOI: 10.1016/j.forsciint.2017.01.023

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  5 in total

1.  Pharmacokinetics and pharmacodynamics of the synthetic cannabinoid, 5F-MDMB-PICA, in male rats.

Authors:  Alex J Krotulski; Nancy Garibay; Donna Walther; Sara E Walton; Amanda L A Mohr; Barry K Logan; Michael H Baumann
Journal:  Neuropharmacology       Date:  2021-09-20       Impact factor: 5.250

2.  Linking in vitro and ex vivo CB1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites.

Authors:  Liesl K Janssens; Simon Hudson; David M Wood; Caitlin Wolfe; Paul I Dargan; Christophe P Stove
Journal:  Arch Toxicol       Date:  2022-08-12       Impact factor: 6.168

3.  Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice.

Authors:  Grant C Glatfelter; John S Partilla; Michael H Baumann
Journal:  Neuropsychopharmacology       Date:  2021-11-20       Impact factor: 8.294

4.  Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.

Authors:  Bogdan Tokarczyk; Agnieszka Jurczyk; Justyna Krupińska; Piotr Adamowicz
Journal:  Forensic Sci Med Pathol       Date:  2022-06-14       Impact factor: 2.456

5.  Detection of a New Tert-Leucinate Synthetic Cannabinoid 5F-MDMB-PICA and Its Metabolites in Human Hair: Application to Authentic Cases.

Authors:  Yan Shi; Liying Zhou; Le Li; Mengxi Liu; Huosheng Qiang; Min Shen; Baohua Shen; Hang Chen; Olaf H Drummer; Wanhui Liu; Hejian Wu; Ping Xiang
Journal:  Front Chem       Date:  2020-11-26       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.